Navigation Links
NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks
Date:3/4/2015

(PRWEB) March 04, 2015

Dr. Christopher Asandra, M.D., Founder and Chief Medical Officer of NuMale Medical Center today lamented the FDA’s recent decision to issue a warning on testosterone replacement therapy (TRT). He argued that FDA’s conclusions are not supported by science, and that the warning could harm men who suffer from testosterone deficiency.

“The FDA appears to have developed a case of “premature equivocation” on testosterone replacement therapy,” said Dr. Asandra. “There is not nearly enough evidence to support the FDA’s conclusions on TRT, and this warning could harm men suffering from legitimate medical conditions. With more scientific evidence indicating preventative and protective benefits effect from the use of testosterone, as opposed to increased risk, the FDA should have waited for more information before jumping into the media circus around testosterone.”

In a recent scientific review published in the Mayo Clinic Proceedings, a team led by Harvard Medical School Professor Dr. Abraham Morgentaler looked at TRT and cardiovascular risk. The review, released in January 2015, found that there is no real evidence supporting the purported risks. Instead, the authors illustrated that existing literature indicates a strong relationship between higher serum testosterone concentrations and lower cardiovascular risk factors.

Similarly, the European Medicines Agency agreed late last year that there is no consistent evidence of an increased risk of heart problems with testosterone medicines in men who suffer from a deficiency. That agency also noted that lack of testosterone in men could increase the risk of heart problems.

About NuMale Medical Center
NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation and low sex drive, utilizing a wide range of the most highly respected, FDA-approved treatments. NuMale's innovative services include bio-identical hormone replacement, medical weight loss, NeoGraft hair restoration and the Priapus procedure. Founded and led by accomplished physician Dr. Christopher Asandra, NuMale Medical Center has expanded rapidly since its founding in 2013, with eleven facilities nationwide and many more to come.

Read the full story at http://www.prweb.com/releases/2015/03/prweb12562906.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950
2. Christopher R. Esseltine Joins Holland & Hart’s Healthcare Practice In Salt Lake City
3. Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode
4. Kelly and Mike Get Turned Upside Down by Christopher Harrison from AntiGravity® Fitness
5. St. Christopher Fund Accepting Scholarship Applications for Veterans
6. Medical Breakthrough for Those Suffering from the Inability to Urinate Normally
7. New Study by USC Eye Institute Shows Ranibizumab Reverses Vision Loss in Working-Age U.S. Hispanic and Non-Hispanic Whites Suffering from Diabetic Eye Disease
8. Carrick Brain Center Raises Awareness for Veterans Suffering PTSD and Traumatic Brain Injury
9. ‘Sick, not weak’: Mediaplanet’s "Mental Health” Campaign Dispels Stigmas and Bolsters Support for the One in Five Canadians Suffering Mental Illness
10. New Book Helps Millions of Children Deal With The Emotional Pains of Suffering From Eczema
11. Mexico Now Offers Top Program for Couples Suffering from Male Infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: